Narrative review / 2014
A review suggests statins reduce serum CoQ10 levels, while CoQ10 supplementation may improve myopathy symptoms.
This review examined studies from CINAHL, Medline, Health Source, and the Cochrane Library to assess statin effects on plasma CoQ10 and the impact of CoQ10 supplementation on statin-related myopathy. Reviewed studies indicated a significant relationship between statin intake and decreased serum CoQ10 levels. A few studies reported benefits in myalgia symptoms or improved serum CoQ10 levels with supplementation at doses between 30 and 200 mg daily, though one study found no benefit. No adverse risks of supplementation were reported across the studies.
- Study type
- Literature review
- Who was studied
- Patients taking statins
- What was measured
- Plasma CoQ10 levels and symptoms of statin-related myopathy
THE PAPER
Statins' effect on plasma levels of Coenzyme Q10 and improvement in myopathy with supplementation.
Littlefield N, Beckstrand RL, Luthy KE. J Am Assoc Nurse Pract, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.